BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for June 12, 2026

June 12, 2026
New hires and promotions in the biopharma and med-tech industries, including: Ambros, Aspen, Bighat, Dentsply, Fedora, Harbour, Oriva, Palisade, Phoremost, Poxel, Relmada, Viking, Vir.
Read More

Appointments and advancements for June 11, 2026

June 11, 2026
New hires and promotions in the biopharma and med-tech industries, including: Aldeyra, Covalon, Cytospire, Hansa, Phoremost, Rakuten, Vascarta.
Read More

Appointments and advancements for June 10, 2026

June 10, 2026
New hires and promotions in the biopharma and med-tech industries, including: Allergene, Antag, Apollo, Avanzanite, Biostem, Bpgbio, Catalym, Complete Genomics, Cvrx, Kymera, Lakefront, Mitorx, Orexo, Perrigo, Resvita, Savara, Syntis, Vergent.
Read More

Appointments and advancements for June 9, 2026

June 9, 2026
New hires and promotions in the biopharma and med-tech industries, including: Advancell, Dualitas, Eikon, Ionis, Medera, Protego, Soley.
Read More

Appointments and advancements for June 9, 2026

June 9, 2026
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Kazia.
Read More

Appointments and advancements for June 8, 2026

June 8, 2026
New hires and promotions in the biopharma and med-tech industries, including: Abcellera, Genovyn, Livanova, Tempest.
Read More

Appointments and advancements for June 5, 2026

June 5, 2026
New hires and promotions in the biopharma and med-tech industries, including: Alera, Beyondspring, Quanterix.
Read More

Appointments and advancements for June 4, 2026

June 4, 2026
New hires and promotions in the biopharma and med-tech industries, including: Celularity, Cocrystal, Corrixr, Cue Biopharma, Defence, Jenavalve, Natera, Neuronetics, Noah, Ovid, Precision, Transverse.
Read More

Appointments and advancements for June 3, 2026

June 3, 2026
New hires and promotions in the biopharma and med-tech industries, including: Airna, Altessa, Enyo, Evotec, Fundamental, Kazia, Minerva, Oncolytics Biotech, Prokidney, Rocket One, Spyglass, Tavo.
Read More

Appointments and advancements for June 2, 2026

June 2, 2026
New hires and promotions in the biopharma and med-tech industries, including: Actinium, Aditxt, Defence, Fractyl, Lungpacer.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 325 326 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing